Clinical Evaluation of Surrounding Electroacupuncture in the Treatment of Acute Lateral Ankle Sprain

Launched by THE THIRD AFFILIATED HOSPITAL OF ZHEJIANG CHINESE MEDICAL UNIVERSITY · Dec 13, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called electroacupuncture for people with acute lateral ankle sprains, which are injuries to the outer side of the ankle. The researchers want to see how effective electroacupuncture is when combined with another acupuncture method compared to a control group that receives ice and rest. The trial will use ultrasound technology to assess the results and is currently looking for participants.

To be eligible for this study, you must be between 18 and 60 years old and have a mild to moderate ankle sprain that happened within the last 48 hours. It’s important that your skin over the injured area is intact. Unfortunately, those with more severe injuries, fractures, certain medical conditions, or issues with the skin cannot participate. If you join the trial, you will receive either the acupuncture treatment or the control treatment, and all procedures will be closely monitored by medical professionals. This study aims to provide valuable insights into new ways to treat ankle sprains effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Meets the diagnostic criteria for a grade I or II injury;
• • Onset time≤48h;
• • The patient aged between18 and 60, gender is not limited;
• • The skin of the ankle joint on the affected side is intact, without breakage or ulceration;
• Exclusion Criteria:
• • Combined with ankle fracture;
• • Grade III injury or complete ligament rupture;
• • Those who cannot comply with the treatment program. Those with keloid, localized combination of other skin diseases, and those who are not suitable for electroacupuncture treatment;
• • Those with serious cardiovascular, cerebrovascular, hepatic, renal, hematopoietic system or systemic failure, connective tissue disease, hemophilia, diabetes mellitus, malignant tumors, and those who are prone to bleeding tendency.